Self‐Assembled Aza‐Boron‐Dipyrromethene‐Based H 2 S Prodrug for Synergistic Ferroptosis‐Enabled Gas and Sonodynamic Tumor Therapies
Advanced Science · 2024-08 · 11 (30)
DOI: 10.1002/advs.202309542 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 13.06.2024. Verfasst von Jiajia Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, P. R. China. Hauptthemen laut MEDLINE: Ferroptosis, Hydrogen Sulfide, Prodrugs, Glioblastoma. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Science and Technology Program, Basic Research Program of Shanghai Municipal Government.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) is the most aggressive and lethal subtype of gliomas of the central nervous system. The efficacy of sonodynamic therapy (SDT) against GBM is significantly reduced by the expression of apoptosis‐inhibitory proteins in GBM cells. In this study, an intelligent nanoplatform (denoted as Aza‐BD@PC NPs) based on the aza‐boron‐dipyrromethene dye and phenyl chlorothionocarbonate‐modified DSPE‐PEG molecules is developed for synergistic ferroptosis‐enabled gas therapy (GT) and SDT of GBM. Once internalized by GBM cells, Aza‐BD@PC NPs showed effective cysteine (Cys) consumption and Cys‐triggered hydrogen sulfide (H 2 S) release for ferroptosis‐enabled GT, thereby disrupting homeostasis in the intracellular environment, affecting GBM cell metabolism, and inhibiting GBM cell proliferation. Additionally, the released Aza‐BD generated abundant singlet oxygen ( 1 O 2 ) under ultrasound irradiation for favorable SDT. In vivo and in vitro evaluations demonstrated that the combined functions of Cys consumption, H 2 S production, and 1 O 2 production induced significant death of GBM cells and markedly inhibited tumor growth, with an impressive inhibition rate of up to 97.5%. Collectively, this study constructed a cascade nanoreactor with satisfactory Cys depletion performance, excellent H 2 S release capability, and prominent reactive oxygen species production ability under ultrasound irradiation for the synergistic ferroptosis‐enabled GT and SDT of gliomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, P. R. China.
- Department of Neurosurgery, Changzheng Hospital, Naval Medical University, Shanghai, 200003, P. R. China.
- School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China.
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou Institute of Shanghai University, Wenzhou, 325088, P. R. China.
- Shanghai Institute of Materdicine, Shanghai, 200051, P. R. China.
ORCID-Profile: Yu Chen
Förderung
- National Natural Science Foundation of China
- Shanghai Science and Technology Program
- Basic Research Program of Shanghai Municipal Government
- Shanghai Rising-Star Program
Zitieren
APA
Zhao, J., Bian, E., Zhang, R., Xu, T., Nie, Y., Wang, L., Jin, G., Xie, H., Xiang, H., Chen, Y., & Wu, D. (2024). Self‐Assembled Aza‐Boron‐Dipyrromethene‐Based H 2 S Prodrug for Synergistic Ferroptosis‐Enabled Gas and Sonodynamic Tumor Therapies. Advanced Science, 11(30). https://doi.org/10.1002/advs.202309542
Vancouver
Zhao J, Bian E, Zhang R, Xu T, Nie Y, Wang L, et al. Self‐Assembled Aza‐Boron‐Dipyrromethene‐Based H 2 S Prodrug for Synergistic Ferroptosis‐Enabled Gas and Sonodynamic Tumor Therapies. Advanced Science. 2024;11(30). doi:10.1002/advs.202309542
BibTeX
@article{Zhao2024,
author = {Zhao, Jiajia and Bian, Erbao and Zhang, Renwu and Xu, Tao and Nie, Yang and Wang, Linqi and Jin, Gui and Xie, Han and Xiang, Huijing and Chen, Yu and Wu, Dejun},
title = {Self‐Assembled Aza‐Boron‐Dipyrromethene‐Based H 2 S Prodrug for Synergistic Ferroptosis‐Enabled Gas and Sonodynamic Tumor Therapies},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {30},
doi = {10.1002/advs.202309542}
}
EUVIMED